New TnBC Medical Study of Leronlimab: Abstract
Post# of 148282
(Total Views: 1133)
Posted On: 08/17/2020 2:54:41 PM
New TnBC Medical Study of Leronlimab:
Abstract CT233: Phase Ib/II study of leronlimab (PRO 140) combined with carboplatin in CCR5+ mTNBC patients
Massimo Cristofanilli, Milana Dolezal, Jay Lalezari , Hallgeir Rui, Bruce Patterson , Cha-Mei Tang, Daniel Adams, Qiang Zhang, Kazem Kazempour, Nader Pourhassan , Natalie Rabb and Kush Dhody
https://cancerres.aacrjournals.org/content/80...ment/CT233
Abstract CT233: Phase Ib/II study of leronlimab (PRO 140) combined with carboplatin in CCR5+ mTNBC patients
Massimo Cristofanilli, Milana Dolezal, Jay Lalezari , Hallgeir Rui, Bruce Patterson , Cha-Mei Tang, Daniel Adams, Qiang Zhang, Kazem Kazempour, Nader Pourhassan , Natalie Rabb and Kush Dhody
https://cancerres.aacrjournals.org/content/80...ment/CT233
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼